High-throughput technologies have transformed how we research the roles of genes and other biomolecules in the context of disease. But the sheer volume of data being produced also complicates the process of identifying meaningful disease biomarkers and actionable insights. Genetic evidence from the scientific literature can help you prioritize features that might otherwise be lost in big data.
Learn how to you can leverage genomic intelligence from Genomenon to:
- Understand mechanisms of genetic disease and discover genetic biomarkers for Identification and validation of new drug targets at scale
- Streamline regulatory approvals for label expansion of indications to optimize your investment in new therapeutics
- Determine trial selection criteria and detailed patient profiles to better classify responders and non-responders
Bio-IT World Best of Show 2023
The 2023 Best of Show Awards offer exhibitors of the Bio-IT World Conference & Expo an exclusive opportunity to distinguish and highlight their products, whether an innovative application, technology, tool, or solution.
The Bio-IT World community is invited to identify exceptional innovation in technologies used by life science professionals, voting on most impactful new products of the year. Genomenon has two new products in the running for this year’s award competition: